Vanda Pharmaceuticals
VNDA
VNDA
116 hedge funds and large institutions have $342M invested in Vanda Pharmaceuticals in 2016 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 37 increasing their positions, 38 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
14% less capital invested
Capital invested by funds: $396M → $342M (-$54.6M)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Holders
116
Holding in Top 10
4
Calls
$1.72M
Puts
$1.48M
Top Buyers
| 1 | +$5.29M | |
| 2 | +$5.28M | |
| 3 | +$2.12M | |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$1.25M |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$1.17M |
Top Sellers
| 1 | -$10.2M | |
| 2 | -$3.93M | |
| 3 | -$3.4M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$2.94M |
| 5 |
Skandinaviska Enskilda Banken (SEB)
Stockholm,
Sweden
|
-$2.52M |